Cue Biopharma Inc Sustainability Reports
Cue Biopharma Inc. is a clinical-stage biopharmaceutical company that designs and develops a novel class of biologic drugs to selectively modulate disease-relevant T cells for treating autoimmune diseases and cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300PBW78KZA33WC97
3 reports from 2020 to 2023
Company Profile
Cue Biopharma Inc. is a clinical-stage biopharmaceutical company that designs and develops a novel class of biologic drugs to selectively modulate disease-relevant T cells for treating autoimmune diseases and cancer.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
